Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies
出版年份 2021 全文链接
标题
Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies
作者
关键词
Matrix metalloproteinase (MMP), Extracellular matrix (ECM), Cancer, Clinical trial, Matrix metalloproteinase inhibitor (MMPI), Hematological malignancy
出版物
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 223, Issue -, Pages 113623
出版商
Elsevier BV
发表日期
2021-06-12
DOI
10.1016/j.ejmech.2021.113623
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- miR-202-3p negatively regulates MMP-1 to inhibit the proliferation, migration and invasion of lung adenocarcinoma cells
- (2021) Yong Li et al. CELL CYCLE
- Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy
- (2021) Gal Yosef et al. BIOCHEMICAL JOURNAL
- Selective inhibition of matrix metalloproteinase 10 (MMP10) with a single-domain antibody
- (2020) Amir S. Razai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemia
- (2020) Divij Verma et al. LEUKEMIA
- ADAM10 promotes cell growth, migration, and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p
- (2020) Quan Yuan et al. Cancer Cell International
- Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma
- (2020) Salvatore Napoli et al. Cells
- Structure and Function of Human Matrix Metalloproteinases
- (2020) Helena Laronha et al. Cells
- Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
- (2020) Maryam Raeeszadeh-Sarmazdeh et al. Cells
- Inhibiting Matrix Metalloproteinase-2 Activation by Perturbing Protein–Protein Interactions Using a Cyclic Peptide
- (2020) Priyanka Sarkar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins
- (2020) Marcus Bauer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MMP-9 affects gene expression in chronic lymphocytic leukemia revealing CD99 as an MMP-9 target and a novel partner in malignant cell migration/arrest
- (2019) Noemí Aguilera-Montilla et al. ONCOGENE
- Design and Structural Evolution of Matrix Metalloproteinase Inhibitors
- (2019) Thomas Fischer et al. CHEMISTRY-A EUROPEAN JOURNAL
- Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer
- (2019) Georgina Gonzalez-Avila et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Genetic abnormalities and pathophysiology of MDS
- (2019) Naoko Hosono International Journal of Clinical Oncology
- Chronic lymphocytic leukemia: 2019 update on diagnosis, risk stratification and treatment
- (2019) Michael Hallek AMERICAN JOURNAL OF HEMATOLOGY
- A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential
- (2019) Emily Gobin et al. BMC CANCER
- Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases
- (2019) Gregg B. Fields Frontiers in Immunology
- Synthesis, anticancer activity, structure–activity relationship and binding mode of interaction studies of substituted pentanoic acids
- (2019) Sanchita Dutta et al. Future Medicinal Chemistry
- The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
- (2019) Gregg B. Fields Cells
- Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo
- (2019) Hong-Yuan Lu et al. PHARMACOLOGICAL RESEARCH
- Pathological and therapeutic aspects of matrix metalloproteinases: implications in childhood leukemia
- (2019) Yi-Hsuan Hsiao et al. CANCER AND METASTASIS REVIEWS
- Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP signalling
- (2019) Guohua Zhu et al. PHARMACEUTICAL BIOLOGY
- Role of Matrix Metalloproteinases in Angiogenesis and Cancer
- (2019) Saray Quintero-Fabián et al. Frontiers in Oncology
- A catalytically inactive gelatinase B/MMP-9 mutant impairs homing of chronic lymphocytic leukemia cells by altering migration regulatory pathways
- (2018) Elvira Bailón et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Significance of MMP-1 in EGFR-TKI–Resistant Lung Adenocarcinoma: Potential for Therapeutic Targeting
- (2018) Ryoko Saito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Advances in the discovery of cathepsin K inhibitors on bone resorption
- (2018) Jun Lu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
- (2018) Arthur Winer et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
- (2018) Toshie Yoneyama et al. Journal of Cancer
- New and emerging therapies for acute myeloid leukaemia
- (2018) Julian R Davis et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells
- (2018) Aheli Majumder et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview
- (2017) Nilanjan Adhikari et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line
- (2017) Avinaba Mukherjee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation
- (2017) Robert H. Scannevin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PKCζ, MMP-2 and MMP-9 expression in lung adenocarcinoma and association with a metastatic phenotype
- (2017) Xiaoshan Cai et al. Molecular Medicine Reports
- NF-κB inhibition is associated with OPN/MMP-9 downregulation in cutaneous melanoma
- (2017) Claudio Guarneri et al. ONCOLOGY REPORTS
- Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies?
- (2017) Sk. Abdul Amin et al. PHARMACOLOGICAL RESEARCH
- Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia
- (2017) Milena Gusella et al. TUMOR BIOLOGY
- MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma
- (2017) Zhihua Yao et al. TUMOR BIOLOGY
- Triticumoside induces apoptosis via caspase-dependent mitochondrial pathway and inhibits migration through downregulation of MMP2/9 in human lung cancer cells
- (2016) Barun Poudel et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Extracellular matrix structure
- (2016) Achilleas D. Theocharis et al. ADVANCED DRUG DELIVERY REVIEWS
- Punica granatum (pomegranate) leaves extract induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in non-small cell lung cancer in vitro
- (2016) Yali Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays
- (2016) Nilanjan Adhikari et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Timosaponin AIII inhibits migration and invasion of A549 human non-small-cell lung cancer cells via attenuations of MMP-2 and MMP-9 by inhibitions of ERK1/2, Src/FAK and β-catenin signaling pathways
- (2016) Okkeun Jung et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology
- (2016) Brandon J. Rose et al. DISEASE MARKERS
- Clinical and prognostic role of matrix metalloproteinase-2, -9 and their inhibitors in breast cancer and liver diseases: A review
- (2016) A. Daniele et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Matrix metalloproteinases in stem cell mobilization
- (2015) Gerd Klein et al. MATRIX BIOLOGY
- Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinase
- (2015) CHUNHUAI WANG et al. Molecular Medicine Reports
- Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer
- (2015) Derek C. Marshall et al. PLoS One
- Cancer stem cells and tumor metastasis
- (2014) SHUANG LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A Novel CD44-binding Peptide from the Pro-Matrix Metalloproteinase-9 Hemopexin Domain Impairs Adhesion and Migration of Chronic Lymphocytic Leukemia (CLL) Cells
- (2014) Estefanía Ugarte-Berzal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen
- (2014) E. Bailon et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1′ Pocket in the Design of Selective, Small Molecule Inhibitors
- (2014) Benjamin Fabre et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
- (2014) Antonietta Farina et al. Cancers
- Water-Soluble MMP-9 Inhibitor Prodrug Generates Active Metabolites That Cross the Blood–Brain Barrier
- (2013) Wei Song et al. ACS Chemical Neuroscience
- Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in human leukemia cells
- (2013) Wen-Hsin Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview
- (2013) Ajay Kumar Chaudhary et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Missing the target: matrix metalloproteinase antitargets in inflammation and cancer
- (2013) Antoine Dufour et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- MT1-MMP plays a critical role in hematopoiesis by regulating HIF-mediated chemokine/cytokine gene transcription within niche cells
- (2012) C. Nishida et al. BLOOD
- MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
- (2012) A M J Langers et al. BRITISH JOURNAL OF CANCER
- CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability
- (2012) Wen-Hsin Liu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds α4β1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells
- (2012) Estefanía Ugarte-Berzal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl
- (2012) Ying-Jung Chen et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β
- (2012) Brenda L. Petrella et al. Cancer Medicine
- Self-Renewing Hematopoietic Stem Cell Is the Primary Target in Pathogenesis of Human Chronic Lymphocytic Leukemia
- (2011) Yoshikane Kikushige et al. CANCER CELL
- Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9
- (2011) A. Dufour et al. CANCER RESEARCH
- Selective Water-Soluble Gelatinase Inhibitor Prodrugs
- (2011) Major Gooyit et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Evaluation of a Non-Zn Chelating, Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitor for Potential Intra-articular Treatment of Osteoarthritis
- (2011) Christian Gege et al. JOURNAL OF MEDICINAL CHEMISTRY
- Matrix Metalloproteinase-9 Promotes Chronic Lymphocytic Leukemia B Cell Survival through Its Hemopexin Domain
- (2010) Javier Redondo-Muñoz et al. CANCER CELL
- Temporal and Spatial Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Following Myocardial Infarction
- (2010) Merry L. Lindsey et al. Cardiovascular Therapeutics
- α-Mangostin Suppresses Phorbol 12-myristate 13-acetate-Induced MMP-2/MMP-9 Expressions via αvβ3 Integrin/FAK/ERK and NF-κB Signaling Pathway in Human Lung Adenocarcinoma A549 Cells
- (2010) Yuan-Wei Shih et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Activation of fibroblasts in cancer stroma
- (2010) Kati Räsänen et al. EXPERIMENTAL CELL RESEARCH
- Role of Matrix Metalloproteinase-9 Dimers in Cell Migration
- (2010) Antoine Dufour et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Membrane Protease Regulates Energy Production in Macrophages by Activating Hypoxia-inducible Factor-1 via a Non-proteolytic Mechanism
- (2010) Takeharu Sakamoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway
- (2010) Wen-Hsin Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease
- (2010) Daniel P. Becker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?
- (2010) S. Rivera et al. JOURNAL OF NEUROSCIENCE
- The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer
- (2010) Roy M. Bremnes et al. Journal of Thoracic Oncology
- The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells
- (2010) Chunling Wang et al. LEUKEMIA RESEARCH
- Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-β in melanoma development and progression
- (2010) Malaponte ONCOLOGY REPORTS
- Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers☆
- (2010) Bal L. Lokeshwar PHARMACOLOGICAL RESEARCH
- Sulfonate-Containing Thiiranes as Selective Gelatinase Inhibitors
- (2010) Sebastian A. Testero et al. ACS Medicinal Chemistry Letters
- Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models
- (2009) Miriam Fanjul-Fernández et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics
- (2009) David Rodríguez et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- VEGF/VEGFR2 interaction down-regulates matrix metalloproteinase-9 via STAT1 activation and inhibits B chronic lymphocytic leukemia cell migration
- (2009) E. Ugarte-Berzal et al. BLOOD
- A Potent Gelatinase Inhibitor with Anti-Tumor-Invasive Activity and its Metabolic Disposition
- (2009) Mijoon Lee et al. Chemical Biology & Drug Design
- Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation
- (2009) Håkon Reikvam et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Catalytic Domain Architecture of Metzincin Metalloproteases
- (2009) F. Xavier Gomis-Rüth JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13†
- (2009) Lauren G. Monovich et al. JOURNAL OF MEDICINAL CHEMISTRY
- mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: Potential role of TIMP1 as an adverse prognostic factor
- (2009) Carlos Alberto Scrideli et al. LEUKEMIA RESEARCH
- In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia
- (2009) Pascale Schneider et al. LEUKEMIA RESEARCH
- 4 1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells
- (2008) J. Redondo-Munoz et al. BLOOD
- Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma
- (2008) Brett T. Brinker et al. CANCER
- Zinc-Binding Groups Modulate Selective Inhibition of MMPs
- (2008) Arpita Agrawal et al. ChemMedChem
- Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes
- (2008) Erica Travaglino et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite Inhibition
- (2008) Janelle L. Lauer-Fields et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of the hemopexin domain of matrix metalloproteinases in cell migration
- (2008) Antoine Dufour et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Quinazolinones and Pyrido[3,4-d]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis
- (2008) Jie Jack Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia
- (2008) Florent Poyer et al. LEUKEMIA RESEARCH
- Leukemia Stem Cells and Human Acute Lymphoblastic Leukemia
- (2008) Kathrin M. Bernt et al. SEMINARS IN HEMATOLOGY
- Treatment of Childhood Acute Lymphoblastic Leukemia
- (2008) Martin Stanulla et al. SEMINARS IN HEMATOLOGY
- MMPs as therapeutic targets—Still a viable option?
- (2007) B FINGLETON SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started